Infliximab Weakens COVID Antibody Response for Patients With IBD

Patients treated with infliximab for inflammatory bowel disease (IBD) showed significantly reduced response to COVID-19 antibodies, compared with those treated […]
» Read morenohealthproblemsnews.com
Home »
Patients treated with infliximab for inflammatory bowel disease (IBD) showed significantly reduced response to COVID-19 antibodies, compared with those treated […] (Reuters Health) – Children with Hirschsprung disease may be at increased risk for developing inflammatory bowel disease, a Canadian study […]
Infliximab Weakens COVID Antibody Response for Patients With IBD
Hirschsprung Disease Tied to Increased Risk of Inflammatory Bowel Disease